121 related articles for article (PubMed ID: 34462244)
1. Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.
Tao Y; Yu YQ; Liu YY; Jia M; Gao L
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e7-e14. PubMed ID: 34462244
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
3. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
[TBL] [Abstract][Full Text] [Related]
4. Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.
Giri S; Pathak R; Martin MG; Bhatt VR
Leuk Lymphoma; 2016 Feb; 57(2):385-391. PubMed ID: 26084205
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
Elliott MA; Letendre L; Tefferi A; Hogan WJ; Hook C; Kaufmann SH; Pruthi RK; Pardanani A; Begna KH; Ashrani AA; Wolanskyj AP; Al-Kali A; Litzow MR
Eur J Haematol; 2012 Mar; 88(3):237-43. PubMed ID: 22023492
[TBL] [Abstract][Full Text] [Related]
6. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
[TBL] [Abstract][Full Text] [Related]
7. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
[TBL] [Abstract][Full Text] [Related]
8. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Adult Acute Promyelocytic Leukemia: A Decade Experience.
Yedla RP; Bala SC; Pydi VR; Kuruva SP; Chennamaneni R; Konatam ML; Paul TR; Gundeti S
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e158-e164. PubMed ID: 31992504
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
[TBL] [Abstract][Full Text] [Related]
12. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?
Murray CK; Estey E; Paietta E; Howard RS; Edenfield WJ; Pierce S; Mann KP; Bolan C; Byrd JC
J Clin Oncol; 1999 Jan; 17(1):293-7. PubMed ID: 10458245
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis.
Li G; Wu J; Li R; Pan Y; Ma W; Xu J; Nan M; Hou L
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e78-e84. PubMed ID: 36567214
[TBL] [Abstract][Full Text] [Related]
14. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
[TBL] [Abstract][Full Text] [Related]
15. Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States.
Jamy OH; Godby R; Dhir A; Costa LJ; Xavier AC
Cancer; 2021 Aug; 127(16):2966-2973. PubMed ID: 33891351
[TBL] [Abstract][Full Text] [Related]
16. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.
Rego EM; Kim HT; Ruiz-Argüelles GJ; Undurraga MS; Uriarte Mdel R; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Martinez L; Meillón LA; Gómez-Almaguer D; Kwaan HC; Garcés-Eisele J; Gallagher R; Niemeyer CM; Schrier SL; Tallman M; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA
Blood; 2013 Mar; 121(11):1935-43. PubMed ID: 23319575
[TBL] [Abstract][Full Text] [Related]
17. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
[TBL] [Abstract][Full Text] [Related]
19. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
20. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
